Success Story: NIW Approved Without RFE! Computational Biology Researcher Advancing Human Microbiome and Microbial Transmission Research
Client’s Testimonial:
"Thank you for your help with the NIW petition. Excellent experience and great advice were given at any step of the process. When help was needed, I always received a prompt and clear reply.”
On April 4th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for an Associate Research Scientist in the Field of Computational Biology (Approval Notice).
General Field: Computational Biology
Position at the Time of Case Filing: Associate Research Scientist
Country of Origin: Italy
State of Residence at the Time of Filing: Connecticut
Approval Notice Date: April 4th, 2026
Processing Time: 18 months, 5 days (Premium Processing Upgrade Requested)
Case Summary:
The client’s approved I-140 National Interest Waiver case was built around a proposed endeavor in computational biology, specifically developing novel methods and data-analysis approaches to investigate the human microbiome and microbial transmission and to better understand the interplay between the microbiome and host genetics. The petition framed this work as important not only within academic research but also for its broader relevance to improving understanding of disease mechanisms and supporting future diagnostic and therapeutic advances.
The case was supported by the client’s Ph.D. in biomolecular sciences, which helped establish the advanced-degree requirement as well as the technical foundation for the proposed endeavor. The petition also noted that the client is currently employed in research in the field, reinforcing that the client is actively engaged in work directly aligned with the endeavor rather than proposing a purely speculative future plan.
To show that the client is well-positioned, the petition highlighted a strong publication and scholarly impact record. The client had produced 21 peer-reviewed journal articles and 2 preprints, with several articles holding leading authorship roles. The petition did not treat publication count alone as sufficient, but instead used it to show sustained productivity and meaningful contribution to important topics in the field.
The petition also emphasized that the client’s work had received 7,547 citations, arguing that this figure mattered because it reflected substantial reliance by other researchers, not just general visibility. From an adjudicator’s perspective, citation evidence is strongest when it helps show that a researcher’s work has influenced how others conduct research, and that was the role it played here. The petition further noted that the client had completed at least 8 peer reviews, which supported the argument that the client is recognized as a trusted expert by peers.
The case also included 2 recommendation letters, which helped explain the significance of the client’s research in practical terms and supported the claim that the client’s past achievements, influence in the field, and ongoing research collectively justified NIW approval. One expert noted:
“When this is taken into consideration alongside the importance of microbiome structure and composition for human health, it is clear that [Client’s] work is of great value to the field and that he is an irreplaceable presence in the research sphere.”
Altogether, the approval reflected a carefully structured NIW presentation showing both the importance of the endeavor and the client’s proven ability to continue advancing it in the United States.